More than a quarter of patients with early-stage cardiogenic shock had to be transferred to a higher level of care, progressed to a worse stage of shock, or died, according to a study in six US ...
PARIS, France—For patients with both aortic stenosis and cardiogenic shock, TAVI with balloon-expandable valves is a “safe and effective treatment,” according to snapshot of data from the Society of ...
Most people who've had a heart attack-or who fear having one-focus on surviving the cardiovascular event itself. But what happens in the hours and days after can be just as critical. One serious ...
The SEISMiC C Study is the third study in the istaroxime cardiogenic shock development program - SEISMiC C is studying more severely ill SCAI Stage C cardiogenic shock patients Windtree has previously ...
Nursing staff interventions regarding shock team activation significantly improved the time of diagnosis and acceptance of patients with cardiogenic shock. A cardiovascular specialty hospital in north ...
Treatment with a novel monoclonal antibody against circulating dipeptidyl peptidase 3 (cDPP3) led to complete reversal of cardiogenic shock in three compassionate use cases in Germany, according to a ...
Windtree Therapeutics, Inc. announced that it is preparing for an interim analysis of its SEISMiC C Phase 2 study of istaroxime, targeting results for July 2025. This global, placebo-controlled, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback